Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.

Saved in:
Bibliographic Details
Title: Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.
Authors: Agiro A; US Medical Affairs, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA. abiy.agiro@astrazeneca.com., Greatsinger A; Analysis Group, Inc., 151 W 42nd Street, 23rd Floor, New York, NY, 10036, USA., Mu F; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Cook EE; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Chen J; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Sundar M; Analysis Group, Inc., 333 S Hope St # 27, Los Angeles, CA, 90071, USA., Zhao A; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA., Colman E; AstraZeneca, 121 Seaport Blvd, Boston, MA, 02210, USA., Malhotra A; US Medical Affairs, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
Source: Advances in therapy [Adv Ther] 2025 Aug; Vol. 42 (8), pp. 3960-3977. Date of Electronic Publication: 2025 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40531443
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Agiro+A%22">Agiro A</searchLink>; US Medical Affairs, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA. abiy.agiro@astrazeneca.com.<br /><searchLink fieldCode="AU" term="%22Greatsinger+A%22">Greatsinger A</searchLink>; Analysis Group, Inc., 151 W 42nd Street, 23rd Floor, New York, NY, 10036, USA.<br /><searchLink fieldCode="AU" term="%22Mu+F%22">Mu F</searchLink>; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Cook+EE%22">Cook EE</searchLink>; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Sundar+M%22">Sundar M</searchLink>; Analysis Group, Inc., 333 S Hope St # 27, Los Angeles, CA, 90071, USA.<br /><searchLink fieldCode="AU" term="%22Zhao+A%22">Zhao A</searchLink>; Analysis Group, Inc., 111 Huntington Ave, 14th Floor, Boston, MA, 02199, USA.<br /><searchLink fieldCode="AU" term="%22Colman+E%22">Colman E</searchLink>; AstraZeneca, 121 Seaport Blvd, Boston, MA, 02210, USA.<br /><searchLink fieldCode="AU" term="%22Malhotra+A%22">Malhotra A</searchLink>; US Medical Affairs, AstraZeneca, 1800 Concord Pike, Wilmington, DE, 19850, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2025 Aug; Vol. 42 (8), pp. 3960-3977. <i>Date of Electronic Publication: </i>2025 Jun 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40531443
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-025-03254-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3960
    Titles:
      – TitleFull: Renin-Angiotensin-Aldosterone System Inhibitor Dosing After Initiation of Outpatient Sodium Zirconium Cyclosilicate Therapy: The GALVANIZE RAASi Real-World Evidence Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Agiro A
      – PersonEntity:
          Name:
            NameFull: Greatsinger A
      – PersonEntity:
          Name:
            NameFull: Mu F
      – PersonEntity:
          Name:
            NameFull: Cook EE
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Sundar M
      – PersonEntity:
          Name:
            NameFull: Zhao A
      – PersonEntity:
          Name:
            NameFull: Colman E
      – PersonEntity:
          Name:
            NameFull: Malhotra A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1